Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2005
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609780A1 Remedy for diabetes
12/28/2005EP1609478A1 Exendin agonist peptide formulations
12/28/2005EP1609466A1 Pharmaceutical compositions and uses thereof in the preparation of a medicament and/or food compostion for the treatment of overweight and/or correlated symptoms in humans and mammalian as well as process of preparation
12/28/2005EP1608685A2 Methods of treating diabetes by blocking vegf-mediated activity
12/28/2005EP1608618A1 Process for the synthesis of amorphous atorvastatin calcium
12/28/2005EP1608398A2 Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
12/28/2005EP1608396A2 Use of soluble cd14 for treatment of diseases
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608367A1 Pramipexole for reducing excessive food intake by children
12/28/2005EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk
12/28/2005EP1608362A1 Stabilized pharmaceutical preparation comprising an amorphous active substance
12/28/2005EP1608355A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1608311A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy
12/28/2005EP1608236A2 Improved dietary fiber containing materials comprising low molecular weight glucan
12/28/2005EP1608235A1 A process for preparation of hypoglycemic foods and formulations thereof
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1367060B1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
12/28/2005EP1364029B1 FUSION PROTEIN comprising hirudin and proinsulin or insulin
12/28/2005EP1326643B1 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
12/28/2005EP1263746B1 Substituted 8, 8a-dihydro-3ah-indeno 1,2-d]thiazoles, a method for their production and their use as medicaments
12/28/2005EP1251843B1 Compositions for delivery of a cortisol antagonist
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1140930B1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP1117411B1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates
12/28/2005EP1082107B8 Controlled release lipoic acid
12/28/2005EP0994093B1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
12/28/2005EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity
12/28/2005EP0682529B2 Antibody for the treatment of insulin dependent diabetes
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1713894A Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/28/2005CN1233656C Unsaturated fatty acid modified insulin and preparing method thereof
12/28/2005CN1233628C Preparation method of 2-hydroxyl-4-methylthio-calcium butyrate
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/28/2005CN1233417C Peptide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
12/28/2005CN1233386C Use of glede tea aqueous extract in preparation of diabetes preventing and treating drug
12/28/2005CN1233377C Fat reducing Chinese drugs for treating simple obesity
12/28/2005CN1233348C Black boned chicken active capsule
12/28/2005CN1233334C Oral liquid for detoxicating and dispelling wind
12/28/2005CN1233315C Sibutramine hydrochloride guttate pill
12/28/2005CN1233281C Full-nutrient convenient slim soup stock
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979741 Acetyl-CoA carboxylase inhibitors
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2188887C Nutritional coffee composition
12/22/2005WO2005121161A1 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121131A1 Dpp-iv inhibitors
12/22/2005WO2005121089A1 Dpp-iv inhibitors
12/22/2005WO2005121080A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005WO2005120487A2 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders
12/22/2005WO2005120485A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005WO2005120484A1 Regulator for physiological functions of ghrelin
12/22/2005WO2005110454A8 Protective binding members of pyy for the treatment of metabolic disorders
12/22/2005WO2005046569A3 Pharmaceutical compositions for the treatment of sars
12/22/2005WO2004105789A8 Grf analog compositions and their use
12/22/2005WO2004093823A3 Polyethelene glycol link glp-1 compounds
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282904 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282897 Methods and compositions for treating diabetes
12/22/2005US20050282894 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
12/22/2005US20050282885 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282822 Therapeutic agents
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282815 Substituted N-(heteroar-beta-yl)aminopyridinecarboxamides or benzamides, e.g., 2-amino-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-N-(4-methylthiazol-2-yl)benzamide; glucokinase activators used to treat diabetes mellitus or obesity
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282746 DNA encoding the receptor, a transformed cell expressing the receptor, producing the receptor by culturing the transformed cells; receptor binding assays; drug screening for agonists, antagonists, or allosteric modulators
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050281895 Slimming cosmetic composition containing a substance inducing the production of IL-6
12/22/2005US20050281889 Nutritional supplement for adults
12/22/2005US20050281888 Nutritional supplement for infants
12/22/2005US20050281864 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock
12/22/2005US20050281804 Administering human recombinant alpha -L-iduronidase, carrier and polysorbate for therapy of mucopolysaccharidosis
12/22/2005DE102004045186A1 Hydratisierte lamellare Phasen oder Liposomen, enthaltend ein Fettmonoamin oder ein kationisches Polymer, das die intrazelluläre Penetration begünstigt, und kosmetische oder pharmazeutische Zusammensetzungen, diese enthaltend, sowie Screeningverfahren nach einer solchen Substanz Hydrated lamellar phases or liposomes, containing a fatty mono-amine or a cationic polymer that promotes intracellular penetration, and cosmetic or pharmaceutical compositions comprising them, as well as screening methods for such substance
12/22/2005CA2576236A1 1-`(3r)-amino-4-(2-fluoro-phenyl)-butyl !-pyrrolidine-(2r)-carboxilic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus
12/22/2005CA2570042A1 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
12/22/2005CA2570041A1 Process for the preparation of nateglinide
12/22/2005CA2569883A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
1 ... 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 ... 1298